Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2015 Aug 15;309(4):C203-4.
doi: 10.1152/ajpcell.00180.2015. Epub 2015 Jun 24.

Seeing is believing: NO therapy for glaucoma? Focus on "Role of nitric oxide in murine conventional outflow physiology"

Affiliations
Editorial

Seeing is believing: NO therapy for glaucoma? Focus on "Role of nitric oxide in murine conventional outflow physiology"

Natasha M Rogers et al. Am J Physiol Cell Physiol. .
No abstract available

PubMed Disclaimer

Comment on

  • Role of nitric oxide in murine conventional outflow physiology.
    Chang JY, Stamer WD, Bertrand J, Read AT, Marando CM, Ethier CR, Overby DR. Chang JY, et al. Am J Physiol Cell Physiol. 2015 Aug 15;309(4):C205-14. doi: 10.1152/ajpcell.00347.2014. Epub 2015 Jun 3. Am J Physiol Cell Physiol. 2015. PMID: 26040898 Free PMC article.

References

    1. Awadalla MS, Thapa SS, Hewitt AW, Craig JE, Burdon KP. Association of eNOS polymorphisms with primary angle-closure glaucoma. Invest Ophthalmol Vis Sci 54: 2108–2114, 2013. - PubMed
    1. Carta F, Supuran CT, Scozzafava A. Novel therapies for glaucoma: a patent review 2007–2011. Expert Opin Ther Patents 22: 79–88, 2012. - PubMed
    1. Chang JY, Stamer WD, Bertrand J, Read AT, Marando CM, Ethier CR, Overby DR. Role of nitric oxide in murine conventional outflow physiology. Am J Physiol Cell Physiol (June 3, 2015). doi:10.1152/ajpcell.00347.2014. - DOI - PMC - PubMed
    1. Ellis DZ. Guanylate cyclase activators, cell volume changes and IOP reduction. Cell Physiol Biochem 28: 1145–1154, 2011. - PubMed
    1. Klein R, Klein BE. The prevalence of age-related eye diseases and visual impairment in aging: current estimates. Invest Ophthalmol Vis Sci 54: ORSF5–ORSF13, 2013. - PMC - PubMed

Substances

LinkOut - more resources